Masimo Appoints New President
Masimo has appointed Tim Benner as president, effective August 3, 2026, according to a company news release.
Masimo has appointed Tim Benner as president, effective August 3, 2026, according to a company news release.
Masimo has appointed Tim Benner as president, effective August 3, 2026, according to a company news release.
Read MoreThree research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.
Read MoreThe collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.
Read MoreThe collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read MoreMagnolia Diagnostics and its owners allegedly billed Medicare for unnecessary respiratory panels performed on seniors during the pandemic, according to the US Justice Dept.
Read MoreA new fundraise will support commercial scale-up and the development of biomarker technology for respiratory disease drug development.
Read MoreThe collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.
Read MoreENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Read MoreDanaher Corp completed the acquisition of Masimo Corp for $9.9 billion.
Read MorePerma Pure and Maxtec have unified under a new parent company, Salaera, to form a global technology platform for breath and gas systems.
Read MoreFor most chronic lung disease patients, their health depends on the consistent clearance of airway secretions. In this Q&A, RT will speak with industry leaders on advances in secretion clearance technology.
Read MoreKreg’s national agreement with Premier includes a breakthrough technology designation for a specialty bed that supports early mobility for bariatric patients.
Read MorePulling Flovent from the market in 2024 resulted in GSK profits and harm to pediatric asthma patients, according to a US Senate investigation reported by CNN.
Read MoreMasimo Corp will be acquired by Danaher Corp for $9.9 billion, according to multiple media reports including Reuters.
Read MoreNurse practitioner topped US News & World Report’s list of 2026 Best Jobs, while respiratory therapist ranked #12 overall and #4 in healthcare careers.
Read MoreZoll appointed Eric Knudsen as its new chief executive officer, effective April 1.
Read MoreDr. Peter Craig Farrell, founder of Resmed Inc, will receive the Horatio Alger Award.
Read More4DMedical’s FDA-cleared CT:VQ provides ventilation and perfusion insights from CT imaging.
Read MoreNeotech Products will partner with Imagine Devices on development of its Trinity Tube, a multifunctional neonatal nasogastric feeding tube concept designed to integrate feeding, vital sign monitoring, and internal respiratory pressure monitoring into a single device.
Read MoreGlaxoSmithKline agreed to reduce costs for certain prescription drugs in the United States, after a direct request from the Trump administration.
Read MoreIntersurgical entered into an agreement to acquire the Acute Care and Interventional Urology businesses of Teleflex.
Read MoreDrive DeVilbiss Healthcare is returning to its original Drive Medical brand across all markets, according to a company announcement.
Read MoreThe company’s Board of Directors has appointed industry veteran and respiratory therapist Todd Austin as Nonin Medical’s next CEO.
Read MoreA US-based jury ordered Apple to pay $634 million for infringing Masimo’s patent for blood oxygen monitoring technology in its Apple Watch.
Read More